Greater Glasgow and Clyde Medicines

Click on the following links to access NHSGGC COVID-19 clinical guidelines published between 22nd June and 10th July 2020. Please note, all the links are on StaffNet and require NHSGGC network access.

Click on the following link to access new and updated clinical guidelines including NHSGGC, SIGN and NICE guidelines. Please note, all the links are on StaffNet and require NHSGGC network access.

Cyproterone acetate: new advice to minimise risk of meningioma 

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines assessed by SMC and considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

DOAC Patient Information Booklet Revised version now available Aim of booklet Direct Oral Anticoagulant (DOAC) Patient Information Booklet was developed for use across NHSGGC in 2018. A revised version is now avai...

Key messages   NHS Scotland and the Care Inspectorate have jointly developed temporary guidance on repurposing medicines within care homes and hospices in the context of the COVID-19 outbreak 

Click on the following links to access new and updated clinical guidelines. Please note, all the links are on StaffNet and require NHSGGC network access.

Click on the following links to access NHSGGC COVID-19 clinical guidelines published between 18th May and 19th June. Please note, all the links are on StaffNet and require NHSGGC network access.  

Standard Operating Procedure and Prescription/Administration Chart Primary care prescribers who wish to prescribe subcutaneous (SC) fluids should refer to the Scottish Palliative Care Guidelines on Subcutaneous Fluids

Patients receiving Systemic Anti-Cancer Therapy (SACT) with suspected or confirmed COVID-19  Patients who develop COVID-19 are at risk of developing a dangerous hyper-inflammatory state (cytokine storm), which ...